p53 signaling in cancer progression and therapy

HE Marei, A Althani, N Afifi, A Hasan, T Caceci… - Cancer cell …, 2021 - Springer
The p53 protein is a transcription factor known as the" guardian of the genome" because of
its critical function in preserving genomic integrity. The TP53 gene is mutated in …

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

X Chen, T Zhang, W Su, Z Dou, D Zhao, X Jin… - Cell Death & …, 2022 - nature.com
TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …

The role and regulation of integrins in cell migration and invasion

MR Chastney, J Kaivola, VM Leppänen… - … Reviews Molecular Cell …, 2024 - nature.com
Integrin receptors are the main molecular link between cells and the extracellular matrix
(ECM) as well as mediating cell–cell interactions. Integrin–ECM binding triggers the …

5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs

X Chen, A Li, BF Sun, Y Yang, YN Han, X Yuan… - Nature cell …, 2019 - nature.com
Abstract Although 5-methylcytosine (m5C) is a widespread modification in RNAs, its
regulation and biological role in pathological conditions (such as cancer) remain unknown …

Every step of the way: integrins in cancer progression and metastasis

H Hamidi, J Ivaska - Nature Reviews Cancer, 2018 - nature.com
Cell adhesion to the extracellular matrix is fundamental to tissue integrity and human health.
Integrins are the main cellular adhesion receptors that through multifaceted roles as …

[HTML][HTML] Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance

J Cooper, FG Giancotti - Cancer cell, 2019 - cell.com
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …

Gain-of-function mutant p53 in cancer progression and therapy

C Zhang, J Liu, D Xu, T Zhang, W Hu… - Journal of molecular …, 2020 - academic.oup.com
Abstract p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite
for cancer development. The p53 gene is the most frequently mutated gene in human …

RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

K Yizhak, F Aguet, J Kim, JM Hess, K Kübler, J Grimsby… - Science, 2019 - science.org
INTRODUCTION Cancer genome studies have contributed to the analysis and discovery of
somatic mutations that drive cancer growth. However, studying the genetic makeup of a …

Mutant p53 in cancer progression and targeted therapies

G Zhu, C Pan, JX Bei, B Li, C Liang, Y Xu, X Fu - Frontiers in oncology, 2020 - frontiersin.org
TP53 is the most frequently mutated tumor suppressor gene in human cancer. The majority
of mutations of p53 are missense mutations, leading to the expression of the full length p53 …

Mutational drivers of cancer cell migration and invasion

NM Novikov, SY Zolotaryova, AM Gautreau… - British journal of …, 2021 - nature.com
Genomic instability and mutations underlie the hallmarks of cancer—genetic alterations
determine cancer cell fate by affecting cell proliferation, apoptosis and immune response …